LifeTech Scientific Corporation (HKG:1302)
Hong Kong
· Delayed Price · Currency is HKD 1.720
+0.010 (0.58%)
Mar 10, 2026, 11:59 AM HKT
LifeTech Scientific Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,967 | 6,437 | 10,881 | 11,945 | 16,946 | 20,590 | Upgrade
|
| Market Cap Growth | 19.47% | -40.85% | -8.91% | -29.51% | -17.70% | 219.88% | Upgrade
|
| Enterprise Value | 6,406 | 5,395 | 9,846 | 10,333 | 15,560 | 20,601 | Upgrade
|
| Last Close Price | 1.72 | 1.39 | 2.35 | 2.58 | 3.66 | 4.45 | Upgrade
|
| PE Ratio | 94.76 | 27.20 | 37.52 | 32.48 | 47.20 | 80.24 | Upgrade
|
| Forward PE | 16.88 | 27.40 | 27.40 | 27.40 | 27.40 | 27.40 | Upgrade
|
| PS Ratio | 5.48 | 4.64 | 7.79 | 9.63 | 14.92 | 26.99 | Upgrade
|
| PB Ratio | 1.95 | 1.74 | 2.97 | 3.62 | 5.46 | 7.35 | Upgrade
|
| P/TBV Ratio | 2.42 | 1.77 | 3.00 | 3.75 | 5.69 | 7.52 | Upgrade
|
| P/FCF Ratio | 12.69 | 48.46 | 45.47 | 65.25 | 83.53 | 74.27 | Upgrade
|
| P/OCF Ratio | 11.92 | 18.82 | 23.63 | 27.21 | 31.30 | 51.21 | Upgrade
|
| PEG Ratio | - | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | Upgrade
|
| EV/Sales Ratio | 4.40 | 3.89 | 7.05 | 8.33 | 13.70 | 27.01 | Upgrade
|
| EV/EBITDA Ratio | 35.95 | 17.57 | 22.80 | 21.66 | 30.59 | 155.06 | Upgrade
|
| EV/EBIT Ratio | 78.19 | 24.18 | 27.21 | 24.76 | 34.66 | 262.64 | Upgrade
|
| EV/FCF Ratio | 10.21 | 40.62 | 41.15 | 56.44 | 76.70 | 74.31 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 1.45 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.04 | 0.04 | 0.06 | 0.10 | 0.80 | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.34 | -0.35 | -0.28 | -0.58 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.22 | -4.08 | -2.98 | -1.95 | -3.52 | -8.55 | Upgrade
|
| Net Debt / FCF Ratio | -2.43 | -9.43 | -5.39 | -5.09 | -8.84 | -4.10 | Upgrade
|
| Asset Turnover | 0.26 | 0.27 | 0.30 | 0.32 | 0.30 | 0.27 | Upgrade
|
| Inventory Turnover | 0.70 | 0.63 | 0.75 | 1.21 | 1.55 | 1.30 | Upgrade
|
| Quick Ratio | 1.70 | 1.73 | 1.77 | 1.80 | 3.40 | 2.61 | Upgrade
|
| Current Ratio | 2.59 | 2.86 | 2.90 | 2.39 | 3.81 | 3.13 | Upgrade
|
| Return on Equity (ROE) | 0.69% | 4.96% | 3.44% | 11.69% | 11.59% | 11.76% | Upgrade
|
| Return on Assets (ROA) | 0.85% | 2.73% | 4.90% | 6.71% | 7.45% | 1.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.02% | 7.98% | 9.46% | 19.66% | 25.20% | 4.39% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.60% | 5.10% | 8.40% | 11.90% | 13.50% | 2.70% | Upgrade
|
| Earnings Yield | 0.99% | 3.68% | 2.67% | 3.08% | 2.12% | 1.25% | Upgrade
|
| FCF Yield | 7.88% | 2.06% | 2.20% | 1.53% | 1.20% | 1.35% | Upgrade
|
| Buyback Yield / Dilution | 1.76% | 1.16% | -0.92% | 3.45% | -3.95% | -5.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.